Selvita S.A. opublikuje najnowsze wyniki programu onkologicznego SEL24 na 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
TitleFile
Raport bieżący EBI 21/2013
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy